Function and role of microparticles in various clinical settings

Area of Science:

• Biochemistry
• Hematology
• Cell Biology

Background:

• Microparticles (MPs) are released from cells and express procoagulant phospholipids.
• MPs are implicated in hemostasis and various clinical diseases, particularly thrombotic disorders.
• Current methods for MP quantification include flow cytometry and novel assays, but clinical utility is debated.

Purpose of the Study:

• To explore the role of microparticles in hemostasis and thrombotic diseases.
• To discuss the clinical significance and controversies surrounding MP quantification.
• To highlight the influence of disease state and treatment on MP characteristics.

Main Methods:

• Review of existing literature on microparticle research.
• Discussion of various analytical methods for MP detection and quantification.
• Analysis of studies correlating MP levels with thrombotic diseases.

Main Results:

• Elevated levels of platelet-, endothelial cell-, and monocyte-derived MPs are observed in most thrombotic diseases.
• The precise causal role of MPs in thrombosis (cause vs. effect) is not fully established.
• MP quantity, origin, and composition vary with disease type, state, and treatment.

Conclusions:

• Microparticle levels are increasingly associated with a growing number of clinical disorders.
• Further research is needed to clarify the clinical significance and diagnostic utility of MPs.
• Understanding MP function and origin is crucial for advancing thrombotic disease management.